Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer

被引:79
作者
Kim, Michael Paul [1 ,2 ]
Zhang, Yun [2 ]
Lozano, Guillermina [2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA
关键词
mutant proteins; p53; mutation; gain of function; stroma; mouse models of cancer; TP53; cancer; GENE-EXPRESSION; STROMAL FIBROBLASTS; FUNCTION MUTATIONS; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; MOUSE MODELS; HUMAN BREAST; IN-VIVO; GAIN; CELLS;
D O I
10.3389/fonc.2015.00249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The functional importance of p53 as a tumor suppressor gene is evident through its pervasiveness in cancer biology. The p53 gene is the most commonly altered gene in human cancer; however, not all genetic alterations are biologically equivalent. The majority of alterations involve p53 missense mutations that result in the production of mutant p53 proteins. Such mutant p53 proteins lack normal p53 function and may concomitantly gain novel functions, often with deleterious effects. Here, we review characterized mechanisms of mutant p53 gain of function in various model systems. In addition, we review mutant p53 addiction as emerging evidence suggests that tumors may depend on sustained mutant p53 activity for continued growth. We also discuss the role of p53 in stromal elements and their contribution to tumor initiation and progression. Lastly, current genetic mouse models of mutant p53 in various organ systems are reviewed and their limitations discussed.
引用
收藏
页数:6
相关论文
共 71 条
[1]   A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis [J].
Adorno, Maddalena ;
Cordenonsi, Michelangelo ;
Montagner, Marco ;
Dupont, Sirio ;
Wong, Christine ;
Hann, Byron ;
Solari, Aldo ;
Bobisse, Sara ;
Rondina, Maria Beatrice ;
Guzzardo, Vincenza ;
Parenti, Anna R. ;
Rosato, Antonio ;
Bicciato, Silvio ;
Balmain, Allan ;
Piccolo, Stefano .
CELL, 2009, 137 (01) :87-98
[2]   Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment [J].
Alexandrova, E. M. ;
Yallowitz, A. R. ;
Li, D. ;
Xu, S. ;
Schulz, R. ;
Proia, D. A. ;
Lozano, G. ;
Dobbelstein, M. ;
Moll, U. M. .
NATURE, 2015, 523 (7560) :352-+
[3]   Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[4]   Stromal fibroblasts in cancer initiation and progression [J].
Bhowmick, NA ;
Neilson, EG ;
Moses, HL .
NATURE, 2004, 432 (7015) :332-337
[5]   Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome [J].
Birch, JM ;
Blair, V ;
Kelsey, AM ;
Evans, DG ;
Harris, M ;
Tricker, KJ ;
Varley, JM .
ONCOGENE, 1998, 17 (09) :1061-1068
[6]   Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[7]   Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression [J].
Bossi, G ;
Lapi, E ;
Strano, S ;
Rinaldo, C ;
Blandino, G ;
Sacchi, A .
ONCOGENE, 2006, 25 (02) :304-309
[8]   Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy [J].
Bossi, Gianluca ;
Marampon, Francesco ;
Maor-Aloni, Revital ;
Zani, Bianca ;
Rotter, Varda ;
Oren, Moshe ;
Strano, Sabrina ;
Blandino, Giovanni ;
Sacchi, Ada .
CELL CYCLE, 2008, 7 (12) :1870-1879
[9]   When mutants gain new powers: news from the mutant p53 field [J].
Brosh, Ran ;
Rotter, Varda .
NATURE REVIEWS CANCER, 2009, 9 (10) :701-713
[10]   Rescuing the function of mutant p53 [J].
Bullock, AN ;
Fersht, A .
NATURE REVIEWS CANCER, 2001, 1 (01) :68-76